Skip to content

Serina Therapeutics, Inc.

SER· NYSECore metricsCIK 1708599

Pharmaceutical preparations553 peers

Last sale
Nov 12, 2026 · -7.79%
Market cap
$37.73M
26.57M shares
Filings
521
$125.00K
Q3 2026+132.1% FY25 yoy
-$7.91M
Q3 2026N/M FY25 yoy
-$7.86M
Q3 2026N/M FY25 yoy
-$16.80M
Q3 2026derivedN/M FY25 yoy
-$0.31
Q3 2026N/M FY25 yoy
$19.40M
Q3 2026−16.8% FY25 yoy
$37.73M
—
290.2×
2.7×
-47.75%
—

FY2025 figures · derived

Price

$1.4264.68%$2.60past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$130.00KFY 2025
$3.15M0FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$130,000reported
FY 20242024-12-31$56,000reported
FY 20232023-12-31$3,153,000 revisedreported
FY 20222022-12-31$34,000reported
FY 20212021-12-31$144,000reported
FY 20202020-12-31$361,000 revisedreported
FY 20192019-12-31$1,728,000reported
FY 20182018-12-31$1,396,000reported
FY 20172017-12-31$1,404,000reported

Segments

Revenue by Segments, FY2023 to FY2025FY2023Reportable Segment · FY2023 · $3.15MFY2024Reportable Segment · FY2024 · $56.00KReportable Segment · FY2024 · $56.00KFY2025Reportable Segment · FY2025 · $130.00K
LineFY2025ShareChange
Reportable Segment$130.00K100%+132.1%
Reportable Segment———
Total$130.00K

From the 10-K filed Mar 25, 2026SER

Pharmaceutical preparations

Serina Therapeutics, Inc. is the 240th largest of the 554 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Serina Therapeutics, Inc. · CIK 1708599 · Engraved from SEC EDGAR